Background To improve our understanding of the natural course of head and neck paragangliomas (HNPGL) and ultimately differentiate between cases that benefit from early treatment and those that are best left untreated, we studied the growth dynamics of 77 HNPGL managed with primary observation. Methods Using digitally available magnetic resonance images, tumor volume was estimated at three time points. Subsequently, nonlinear least squares regression was used to fit seven mathematical models to the observed growth data. Goodness of fit was assessed with the coefficient of determination (R 2 ) and root-mean-squared error.
Introduction
Head and neck paragangliomas (HNPGLs) are generally benign tumors that arise from nonchromaffin paraganglion cells associated with the autonomic nervous system. They are most commonly located at the bifurcation of the carotid artery, but also occur at the nodose and jugular ganglion of the vagus nerve, and within the temporal bone, where they arise at the adventitia of the jugular bulb and along Arnold's and Jacobson's nerve. HNPGLs at other locations, including the thyroid gland and larynx, are extremely rare. [1] [2] [3] Paragangliomas are associated with germline mutations in numerous genes, but mutations in SDHD are currently the most common cause of hereditary paragangliomas. 4 , 5 An increasing number of paragangliomas are detected following surveillance in subjects with a genetic predisposition. 6 These "screening detected" paragangliomas are usually small and asymptomatic. However, as tumors become larger, symptoms related to compression and destruction of adjacent structures, including lower cranial nerve paralysis, may occur. The risk of postoperative cranial nerve dysfunction and other serious complications, including stroke and aspiration/ pneumonia, is relatively low following surgery for small carotid body tumors (8.3-26 .7%) but increases to around 80% when the internal and external carotid arteries are completely encased by tumor tissue. 7 With this in mind, one could argue that all small carotid body tumors should be surgically resected. However, although tumor progression is, with long follow-up, observed in most HNPGL, progression is generally slow and tumors may remain asymptomatic throughout life. [8] [9] [10] Thus, even though surgery for small carotid body tumors is reasonably safe, it remains uncertain whether the benefits outweigh the potential harm caused by treatment. Ideally, we would be able to differentiate between tumors that will never cause symptoms, and those that can best be treated while still small. A better understanding of the natural course of tumors is vital to determine optimal screening intervals, model treatment response, and prevent overtreatment. Unsurprisingly, tumor growth laws have been of interest for over a century, and a variety of mathematical models have been proposed. As most tumors are treated shortly after diagnosis, tumor growth is primarily studied using mouse models or in vitro experiments. [11] [12] [13] We studied growth of HNPGLs using sequential magnetic resonance imaging (MRI) obtained during routine patient care. We previously observed a decreasing growth probability with increasing age and tumor volume, consistent with a decelerating growth pattern. 9 We, therefore, propose that a sigmoidal-shaped growth curve will best describe the growth of HNPGLs.
Methods
Subjects SDHD mutation carriers were identified as previously described. 9 MRI scans were digitally available from 2002 onwards and sufficient follow-up was required to study growth patterns. To avoid selection of an atypically favorable subset of tumors (i.e., tumors that were left untreated while already under surveillance), only patients diagnosed with HNPGL between January 2002 and 2009 were eligible for inclusion. For reasons earlier described, only carotid and vagal body paragangliomas were included. 9 In addition, a minimum of three consecutive MRI scans, before any intervention, was deemed a prerequisite for inclusion. In accordance with the Dutch law, approval of the institutional ethics committee was not obtained because all data were collected in the course of routine patient care.
Volume Estimation
Three perpendicular dimensions were measured using a linear digital caliper tool, at three different time points. Tumor volume was subsequently calculated, assuming an ellipsoid shape (1) . Measurements were performed by two observers (BLH and LMHP) and executed as described in our earlier work on growth of HNPGL.
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The smallest detectable difference (SDD) (i.e., growth or regression) was defined as a volume change of at least 10% for carotid body and 25% for vagal body tumors.
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Mathematical Models
Seven mathematical models of tumor growth were investigated (►Fig. 1).
Linear Model
The simplest model to describe the increase in tumor volume (V) over time (t) is linear growth, with a constant growth rate (r) independent of tumor size.
Exponential Model
If all tumor cells are proliferating at a constant rate, tumor volume increases exponentially. Relative growth rate and thus tumor doubling time (T d ) remain constant over time. 11, 12, 15 
Mendelsohn Model
Although tumor doubling is probably constant during early tumor growth, T d eventually increases. An adjustment to exponential growth was therefore proposed by Mendelsohn in 1963. If α¼ ⅔, growth is proportional to the surface area of the tumor, consistent with linear growth of tumor diameter. 
Gompertz Model
Perhaps the best-known tumor growth model, the Gompertz model was introduced in 1825 as a tool to determine the value of life insurance, and was first used by Anna Laird for the explanation of tumor growth.
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The inflection point of this sigmoid-shaped model occurs once 37% of the maximum tumor volume (V 1 ) has been reached. Thereafter, the growth rate decreases exponentially.
Logistic Model
The second model originating in the 19th century is the Logistic model, also sigmoidal in shape and first used to describe population dynamics. After 50% of the final size has been reached, growth rate decreases linearly with tumor size.
Spratt Model
Spratt et al found that a generalized logistic model with β¼ ¼ best described the growth of human breast cancer.
Bertalanffy Model
The final model we considered is the Bertalanffy model. This model is based on the assumption that growth results from a balance between cell proliferation and cell death. Proliferation occurs in proportion to the surface area (γ¼ ⅔) and loss of tumor mass due to cell death is proportional to tumor volume (with constant β). 11, 13, 18 Areas of necrosis are usually observed when HNPGLs become larger.
Statistics
The mathematical models were fitted using nonlinear least squares regression, with a convergence tolerance for parameters of 10 À6 . Subsequently, the predicted age at onset of neoplastic growth and tumor volume at age 90 were calculated. Considering that the largest HNPGL we have encountered thus far had an estimated volume of 820 cm 3 (patients age $ 60 years), a volume of 1000 cm 3 was regarded as the maximum realistic predicted volume at age 90. Goodness of fit statistics, including the coefficient of determination (R 2 ) and root mean squared error, was used to compare the different models. Kruskal-Wallis one-way analysis of variance, followed by post-hoc tests, was performed to determine statistical significance. Continuous data are, if normally distributed, expressed as mean AE standard deviation, otherwise the median and interquartile range (IQR) are provided. A p-value < 0.05 was considered statistically significant.
Results
Subjects
Sequential MRI was obtained for 47 (61%) carotid body and 30 (39%) vagal body paragangliomas, managed with primary observation. These 77 HNPGL were diagnosed in 44 patients, with a mean age at baseline of 42 AE 12 years. Twenty-seven (61%) subjects were male and 91% carried the c.274G > T, p.Asp92Tyr Dutch founder mutation, while the remaining patients carried other known germline mutations in SDHD. Median tumor volume was 4.6 cm 3 at baseline and increased to 8.0 cm 3 during a mean observation period of 6.9 AE 2.0 years (range: 3.0-11.8).
The median time interval between measurement points was 3.3 years (IQR: 2.6-4.2). The cases presented here were also included in our previous work on growth of HNPGL, which contains a more detailed description of demographics and symptomatology of carotid and vagal body tumors.
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Observed Growth Patterns
Four growth patterns could be distinguished (►Fig. 2). Consistent increase in tumor volume was observed in 62 cases (80.5%), and could be further subdivided in accelerating (►Fig. 2A) and decelerating (►Fig. 2B) growth. Spontaneous regression was observed in five cases (6.5%). In the remaining cases (13%), growth was characterized by alternating progression and regression (►Fig. 2D). In 83%, progression or regression exceeded the previously determined SDD of 10 and 25% for carotid and vagal body tumors, respectively. Particularly when a consistent increase or decrease in tumor volume was observed, growth or regression exceeded the SDD.
Mathematical Models and Goodness of Fit
The median R 2 , IQR, and outliers are shown in ►Fig. 3. A box and whisker diagram is also provided for the root mean squared error (►Fig. 3). There was a statistically significant difference between the different mathematical models, with test statistic H(6) ¼ 80.23 and p < 0.001. Focused comparisons of the mean ranks revealed that the sigmoidal-shaped growth curves (logistic, Spratt, Gompertz, and Bertalanffy equation) better described the observed data compared with the linear, exponential, and Mendelsohn equations. Within the two groups (sigmoidal and nonsigmoidal-shaped growth curves), there was no statistically significant difference. An example of all models fitted to patient data is presented in ►Fig. 4.
A realistic predicted age at onset (i.e., after conception) can, by the very nature of the proposed models, not be expected if the estimated volume is smaller at the end compared with the start of follow-up. Therefore, these cases (n ¼ 9) were not included in further analysis. Dependent on the mathematical model fitted, the predicted age at onset was regarded as realistic in 28 to 87% of cases, with the median age ranging from 13 to 34 years (►Table 1). In the remaining cases, the estimated volume at birth was generally small (median: 0.32-1.46), although outliers were observed.
Volume at age 90 years was predicted to be < 1000 cm 3 in 41 to 100% of cases, with the median predicted volume ranging from 23.7 to 74.9 cm 3 . A realistic predicted age at onset and volume at age 90 were most often observed for the linear model, followed by the Bertalanffy model.
Discussion
Decelerating tumor growth laws, that is, the Gompertz, logistic, Spratt, and Bertalanffy equations, were better suited to model growth of HNPGLs compared with the linear, exponential, or Mendelsohn models. This finding is in line with a previous observation of decreasing growth rates with increasing volume and age. 9 By definition, none of the investigated models could provide a perfect fit to alternating progression and regression as depicted in ►Fig. 2D. However, as the SDD was only exceeded in one of these cases, we propose growth, or rather the lack of it, was consistent with the plateau phase reached by all sigmoidal-shaped growth curves. As stated by Vaidya and Alexandro, in addition to providing a good fit, a mathematical model should have a physiological basis.
18 Retardation of cell cycle speed was suggested as the mechanism behind the Gompertzian model. 16 However, this was contradicted by a more recently observed constant mitotic rate in renal cell carcinomas. 11, 20 Likewise, a solid physiological basis is lacking for the logistic and Spratt models. Considering that the Bertalanffy equation is derived from basic cellular principles, we suggest this as an advantage over the other models, a proposal further reinforced by the observation that a realistic age at onset and volume at age 90 were generally predicted by the Bertalanffy model, while this was less clear in the Gompertz, logistic, and Spratt models. As most tumors are treated promptly following diagnosis, studies that use clinical images to model tumor growth are scarce. To the best of our knowledge, this is the first time that the Bertalanffy equation has been successfully fitted to clinically obtained growth data. In agreement with the current analysis, sigmoidal-shaped growth curves have been found to best describe growth of meningiomas and breast carcinomas. 17, 21 Evidence in favor of decelerating tumor growth is further provided by the observation of growth retardation with increasing age and volume, not only in paragangliomas but also in other benign and malignant tumors. [22] [23] [24] [25] In fact, sigmoid curves were first used to model tumor growth, in view of the ever diminishing growth rate with increasing volume observed in animal models.
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Considering that the Gompertz, logistic, Spratt, and Bertalanffy models all fit our data almost equally well, we propose that the Bertalanffy model will also provide a good fit to growth data of tumors other than paragangliomas. A minimum of three data points is required to model sigmoid-shaped growth curves. Therefore, tumors were only included if three consecutive MRI scans, before any intervention, were available. This may have resulted in a cohort with more favorable tumors, that is, tumors that were left untreated after the second MRI. However, as the equations used are not restricted by growth rate, it is unlikely that the results are influenced by this potential bias.
Although we have not yet evaluated the accuracy of predictions, we believe we have made steps toward unraveling the natural course of HNPGLs. Neoplastic growth was estimated to commence in the third or fourth decade of life in most cases. However, dependent on the mathematical model used, neoplastic growth actually appeared to start prior to conception in a non-negligible number of cases. While this clearly indicates an imperfect fit, it probably indicates that neoplastic growth started very early in life in at least a few of these cases.
Following validation, mathematical models can, once three measurements are available, be used to differentiate between tumors that are prone to cause serious symptoms and those that will most likely remain asymptomatic. Subsequently, one can decide to switch to active treatment or continue conservative management. For a more detailed description of management strategies, we would like to refer to our previous work on HNPGL. Overdiagnosis, that is, detection of occult disease that would have remained unnoticed throughout life, and subsequent overtreatment are not only associated with early detection of hereditary HNPGLs, but are intrinsic to tumor screening. 26 Although it is more or less possible to estimate the incidence of overdiagnosis at a population level, it is not as straightforward when it concerns individual patients. 27, 28 The benefits of screening, such as reduction in disease-specific morbidity and mortality, would be compromised if attempts were made to reduce overdiagnosis. However, by introducing conservative management strategies such as "watchful waiting," harmful side effects of unnecessary treatment can be outliers; therefore, it should be noted that the R 2 was still relatively high for these cases, particularly if only cases with consistent growth or regression were considered (median R 2 ! 0.94).
Fig. 4 An example of the seven investigated mathematical models fitted to observed data points. Although all equations describe the observed data points relatively well, the RMSE of the linear, exponential, and Mendelsohn model ranges from 0.03 to 0.11, while the RMSE of the sigmoidshaped curves was substantially smaller (all < 0.00001). The four sigmoid curves yielded a similar estimated volume at age 90 (as apparent from the results in ►Table 1, this is not true in all cases), while the calculated age at onset was more variable. reduced. Perhaps the most well-known example is active surveillance for men with low-risk prostate cancer. 29 More recently, active surveillance was also introduced for low-risk ductal carcinoma in situ. 30 Well-known applications of a "watchful waiting" strategy for tumors in the head and neck region are for vestibular schwannomas and meningiomas.
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We recognize that knowledge of tumor growth dynamics alone may not be sufficient to differentiate between aggressive and nonaggressive tumors, and additional criteria, including pathologic tumor features (e.g., Gleason upgrading in prostate cancer) or radiologic characteristics (e.g., absence of calcifications in meningiomas), will be required. However, we are now convinced that mathematical modeling of tumor growth is a useful determinant, as it provides not only the opportunity to estimate future tumor growth and thereby reduce overtreatment, but may also be used to estimate the age at onset and improve screening strategies.
Conclusion
Decelerating tumor growth laws best describe growth of carotid and vagal body paragangliomas. In addition, we have provided evidence that the often-neglected Bertalanffy equation can be used to model clinically obtained growth data and, in light of the generally realistic predicted age at onset of neoplastic growth and predicted volume at age 90, may even be the most appropriate mathematical model in this context. A better understanding of tumor growth dynamics will provide possibilities to optimize surveillance and reduce overtreatment.
